600866.SH
Star Lake Bioscience Co., Inc. Zhaoqing Guangdong
SSE · Healthcare · Biotechnology · CN
CNY 4.23
−0.47%Sep 15, 2026, 10:11 UTC
Ningxia Yipin Investment Group and its concert party Tie Xiaorong reduced their combined stake in Star Lake Bioscience from 6.71% to 5.81% by selling 15 million shares via block trades between September 9 and September 14, 2026.
Sep 10, 2026, 06:14 UTC
Star Lake Bioscience held its 2026 interim results briefing on September 10, 2026, where it discussed the amino acid and MSG industries being in a capacity-expansion adjustment cycle with the industry at the bottom of the cycle.
Source:Sep 3, 2026, 07:58 UTC
Xinghu Technology's shareholder Ningxia Yipin Investment Group and its concert party Tie Xiaorong reduced their combined stake from 8.86% to 7.89% between August 6 and September 2, 2026, crossing the 1% threshold.
Aug 19, 2026, 10:03 UTC
Star Lake Bioscience announced its unaudited first-half 2026 operating results, with main business revenue totaling 7.772 billion yuan.
Source:Aug 6, 2026, 09:43 UTC
Ningxia Yipin Investment Group Co., Ltd. and its concerted actor Tie Xiaorong reduced their stake in Xinghu Technology by 19 million shares through centralized bidding and block trades from July 30 to August 5, 2026, lowering their shareholding from 10.00% to 8.86%.
Source: